Department of Medicinal Chemistry, University of Notre Dame, Notre Dame, USA
Swenson Azar is a prominent figure in medicinal chemistry, currently associated with the University of Notre Dame. His expertise lies in biologics and advanced therapeutic systems, focusing on the innovations, complexities, and regulatory challenges surrounding biologics in modern medicine. Azar's work emphasizes monoclonal antibodies and biosimilars, aiming to make treatments more accessible. He has published significant articles, such as one on emerging innovations in biologics for advanced therapies, where he explores the intersection of biotechnology and medical therapies?
Perspective Article
Biologics in Focus: Emerging Innovations and Complexities in Advanced Therapy
Author(s): Swenson Azar*